Early trial tests new shot for skin condition
NCT ID NCT06625177
Summary
This early-stage trial is testing the safety of an experimental medication called TEV-53408 for adults with vitiligo, a condition that causes loss of skin color. The study will involve 38 participants who will receive injections under the skin over 24 weeks, followed by a long monitoring period. The main goal is to see if the treatment is safe and well-tolerated, while also gathering early information on whether it might help repigment the skin.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Teva Investigational Site 12043
Scottsdale, Arizona, 85260, United States
-
Teva Investigational Site 12044
Fremont, California, 94538, United States
-
Teva Investigational Site 12045
Dallas, Texas, 75230, United States
-
Teva Investigational Site 12046
Pasadena, California, 91101, United States
-
Teva Investigational Site 12047
Chicago, Illinois, 60614, United States
-
Teva Investigational Site 12048
Canton, Michigan, 48187, United States
-
Teva Investigational Site 12049
Miramar, Florida, 33025, United States
-
Teva Investigational Site 12051
Irvine, California, 92617, United States
-
Teva Investigational Site 12052
Hot Springs, Arkansas, 71913, United States
-
Teva Investigational Site 12053
Louisville, Kentucky, 40421, United States
-
Teva Investigational Site 12054
Portland, Oregon, 97210, United States
-
Teva Investigational Site 12055
South Jordan, Utah, 84095, United States
-
Teva Investigational Site 12057
Webster, Texas, 77598, United States
Conditions
Explore the condition pages connected to this study.